Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder. [electronic resource]
Producer: 20120831Description: 586-600 p. digitalISSN:- 1941-837X
- Adrenergic alpha-Antagonists -- therapeutic use
- Adult
- Cohort Studies
- Cost-Benefit Analysis
- Drug Therapy, Combination -- economics
- Humans
- Lower Urinary Tract Symptoms -- drug therapy
- Male
- Middle Aged
- Muscarinic Antagonists -- therapeutic use
- Prostatic Hyperplasia -- complications
- Quality of Life
- State Medicine -- economics
- United Kingdom
- Urinary Bladder, Overactive -- complications
- Urination Disorders -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.